Stock screenerAll disclosures →
EDGAR →
IQV
Conviction 39HealthcareScan · Thu, Jun 25, 2026Inverted hammer
IQV$186.39+0.41%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 1.73M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price186.39
Change+0.41%
Gap+0.14%
Rel volume1.42×
Avg volume1.77M
Avg $ vol317.18M
SMA 20180.24
SMA 50173.81
SMA 200195.15
Price vs 50+7.24%
Price vs 200-4.49%
MA stackmixed
50/200 cross—
Supertrendup · 166.03
RSI (14)60
MACD hist-0.03
MACD crossbear · 7d
Stoch %K / %D84 / 66
ADX (14)17
+DI / −DI32 / 22
RSI divergence—
MACD divergence—
ATR %+3.91%
ADR %3.96%
52w high244.29
52w low156.66
From 52w high-23.70%
Above 52w low+18.98%
New 52w highNo
SqueezeOff
Bollinger width13.25%
%B0.76
Donchian pos83.52%
Donchian high191.16
Donchian low162.22
AVWAP (52w high)179.07
vs AVWAP high+4.09%
AVWAP (52w low)173.82
vs AVWAP low+7.23%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d1.42×
Avg vol (14d)1.73M
Avg vol (20d)1.77M
Avg $ vol (20d)317.18M
Market cap31.11B
RS 3m (vs SPY)-0.50%
RS 6m (vs SPY)-23.63%
RS line new highNo
Trend template2/8
Technical rank49.0
1 week+9.21%
1 month+15.06%
3 months+12.53%
6 months-16.93%
1 year+17.54%
YTD-17.30%
P/E22.87
P/B5.00
P/S1.91
P/FCF15.17
EPS7.84
Div yield1.83%
ROE21.86%
ROA4.58%
Debt/Eq2.55
Current0.75
EV/EBITDA13.53
Gross margin—
Net margin8.34%
Rev growth5.87%
EPS growth-0.95%
Price target213.90
Target upside14.76%
Analyst ratingBuy
Institutional108.51%
Ent. value44.99B
Revenue4.15B
Net income274M
Gross profit915M
Free cash flow2.05B
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNYSE
Shares out—
Employees93K
ListedThu, May 9, 2013
Free float160.54M
Float %94.6%
Short interest4.89M
Days to cover2.6d
Short volume47.0%
Squeeze score30 / 100
Next earningsTue, Jul 28, 2026 (33d)
EPS forecast$2.74 · 6 est
Last EPS vs est$2.64 vs $2.51
Last surprise+5.2% beat
Setup gradeD
Conviction39 / 100
Pattern quality—
Tech rank49.0 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmInverted hammer
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Retesting breakoutMay 291 scan
- Setting upJun 161 scan
Congress activity
Disclosed STOCK Act trades in IQV · 7 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Markwayne Mullin senate · traded 2025-12-29 | Buy | $15K–$50K | 2025-12-29 | 2026-01-16 | |
John Boozman senate · R · AR · traded 2025-10-02 | Sell | $1K–$15K | 2025-10-02 | 2025-11-15 | |
Rob Bresnahan house · PA · traded 2025-05-15 | Sell | $1K–$15K | 2025-05-15 | 2025-05-31 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Buy | $15K–$50K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Sell | $1K–$15K | 2025-02-25 | 2025-03-27 | |
Markwayne Mullin senate · traded 2025-02-13 | Buy | $15K–$50K | 2025-02-13 | 2025-02-27 | |
Markwayne Mullin senate · traded 2024-08-20 | Buy | $15K–$50K | 2024-08-20 | 2024-09-19 |
Insider activity
SEC Form 4 transactions in IQV · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
GOGGINS COLLEEN A Director · Deferred Shares · 2026-05-07 | Grant | 214 | $38K | 2026-05-07 | 2026-05-11 |
Fasano Jim Director · Deferred Shares · 2026-05-07 | Grant | 228 | $41K | 2026-05-07 | 2026-05-11 |
DANHAKL JOHN G Director · Deferred Shares · 2026-05-07 | Grant | 185 | $33K | 2026-05-07 | 2026-05-11 |
Wims Morris Leslie Director · Deferred Shares · 2026-05-07 | Grant | 171 | $31K | 2026-05-07 | 2026-05-11 |
GOGGINS COLLEEN A Director · Common Stock · 2026-04-23 | Grant | 1.57K | $0 | 2026-04-23 | 2026-04-27 |
LEONARD JOHN M Director · Common Stock · 2026-04-23 | Grant | 1.57K | $0 | 2026-04-23 | 2026-04-27 |
Stamps Sheila A Director · Deferred Shares · 2026-04-23 | Grant | 1.57K | $252K | 2026-04-23 | 2026-04-27 |
Fasano Jim Director · Deferred Shares · 2026-04-23 | Grant | 1.57K | $252K | 2026-04-23 | 2026-04-27 |
Kaelin William G Jr Director · Deferred Shares · 2026-04-23 | Grant | 1.57K | $252K | 2026-04-23 | 2026-04-27 |
DANHAKL JOHN G Director · Common Stock · 2026-04-23 | Grant | 1.57K | $0 | 2026-04-23 | 2026-04-27 |
SEC filings
EDGAR filings in IQV · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.